Limitations of size as a criterion in the evaluation of adrenal tumors

Background. Size has been considered to be the single best predictor of mal ignancy in adrenal neoplasms that have been identified incidentally. Howeve r, small adrenal cortical cancers have been reported from multiple centers. Methods. We retrospectively evaluated the value of tumor size and other cli nical parameters in the prediction of the presence of adrenal malignancy. Results. The records of 117 patients who underwent evaluation for tumors of the adrenal gland were reviewed. The median tumor size of the adrenal cort ical carcinomas (n = 38 carcinomas) was 9.2 cm (range, 1.7-30 cm); 5 cancer s (13.5%) were smaller than 5.0 cm. The median overall size of the benign t umors, excluding pheochromocytomas, was 4.0 cm (n = 38 carcinomas), 10 beni gn tumors (26%) were larger than 5.0 cm. The imaging features of 4 of 5 sma ll adrenal cancers predicted malignancy; the remaining;patients had hormona lly functioning tumors. The imaging features of 7 of 10 large benign adrena l tumors predicted benign histologic features, including 5 of 5 myelolipoma s. Conclusions. Although size remains a good predictor of the histologic featu res and clinical behavior of adrenal neoplasms, both small adrenal cortical cancers and large benign tumors occur with measurable frequency. High-qual ity imaging studies may be helpful in the identification of relatively smal l adrenal cancers and of characteristic benign lesions that may be selectiv ely followed.